These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 18440934)

  • 1. Percutaneous radiofrequency ablation of liver dome hepatocellular carcinoma invisible on ultrasonography: a new targeting strategy.
    Lee MW; Kim YJ; Park SW; Jeon HJ; Yi JG; Choe WH; Kwon SY; Lee CH
    Br J Radiol; 2008 May; 81(965):e130-4. PubMed ID: 18440934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computed tomography fluoroscopy-guided radiofrequency ablation following intra-arterial iodized-oil injection for hepatocellular carcinomas invisible on ultrasonographic images.
    Takaki H; Yamakado K; Nakatsuka A; Yamada T; Uraki J; Kashima M; Yamanaka T; Shiraki K; Takei Y; Takeda K
    Int J Clin Oncol; 2013 Feb; 18(1):46-53. PubMed ID: 22016114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of patients with hepatocellular carcinoma referred for percutaneous radiofrequency ablation at a tertiary center: analysis focused on the feasibility with the use of ultrasonography guidance.
    Kim JE; Kim YS; Rhim H; Lim HK; Lee MW; Choi D; Shin SW; Cho SK
    Eur J Radiol; 2011 Aug; 79(2):e80-4. PubMed ID: 21514757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
    Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance?
    Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD
    Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.
    Peng ZW; Lin XJ; Zhang YJ; Liang HH; Guo RP; Shi M; Chen MS
    Radiology; 2012 Mar; 262(3):1022-33. PubMed ID: 22357902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fusion imaging-guided radiofrequency ablation for hepatocellular carcinomas not visible on conventional ultrasound.
    Song KD; Lee MW; Rhim H; Cha DI; Chong Y; Lim HK
    AJR Am J Roentgenol; 2013 Nov; 201(5):1141-7. PubMed ID: 24147489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern and chronological change of iodized oil retention in radiofrequency ablation-induced vascular injury area: differentiation from iodized oil retention in recurrent hepatocellular carcinoma on computed tomography.
    Lee JY; Kim YS; Rhim H; Lim HK; Choi D; Lee WJ
    J Comput Assist Tomogr; 2010; 34(3):354-61. PubMed ID: 20498535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technical report: Lipiodol-guided computed tomography for radiofrequency ablation of hepatocellular carcinoma.
    Gandhi S; Iannitti DA; Mayo-Smith WW; Dupuy DE
    Clin Radiol; 2006 Oct; 61(10):888-91. PubMed ID: 16978986
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of dynamic contrast-enhanced ultrasound guidance in ablation therapy for hepatocellular carcinoma.
    Minami Y; Kudo M
    World J Gastroenterol; 2011 Dec; 17(45):4952-9. PubMed ID: 22174544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous radiofrequency ablation of small hepatocellular carcinoma invisible on both ultrasonography and unenhanced CT: a preliminary study of combined treatment with transarterial chemoembolisation.
    Lee MW; Kim YJ; Park SW; Hwang JH; Jung SI; Jeon HJ; Kwon WK
    Br J Radiol; 2009 Nov; 82(983):908-15. PubMed ID: 19433482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
    Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
    J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Planning ultrasound for percutaneous radiofrequency ablation to treat small (≤ 3 cm) hepatocellular carcinomas detected on computed tomography or magnetic resonance imaging: a multicenter prospective study to assess factors affecting ultrasound visibility.
    Kim PN; Choi D; Rhim H; Rha SE; Hong HP; Lee J; Choi JI; Kim JW; Seo JW; Lee EJ; Lim HK
    J Vasc Interv Radiol; 2012 May; 23(5):627-34. PubMed ID: 22387030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of alpha-fetoprotein in detecting hepatocellular carcinoma recurrence after radiofrequency ablation.
    Siripongsakun S; Wei SH; Lin S; Chen J; Raman SS; Sayre J; Tong MJ; Lu DS
    J Gastroenterol Hepatol; 2014 Jan; 29(1):157-64. PubMed ID: 24354994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-guided radiofrequency ablation for hepatocellular carcinomas that were undetectable at US: therapeutic effectiveness and safety.
    Park BJ; Byun JH; Jin YH; Won HJ; Shin YM; Kim KW; Park SJ; Kim PN
    J Vasc Interv Radiol; 2009 Apr; 20(4):490-9. PubMed ID: 19328427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous radiofrequency ablation with artificial ascites for hepatocellular carcinoma in the hepatic dome: initial experience.
    Rhim H; Lim HK; Kim YS; Choi D
    AJR Am J Roentgenol; 2008 Jan; 190(1):91-8. PubMed ID: 18094298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
    Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
    Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.